| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1993.11.9.1661 |
| P698 | PubMed publication ID | 8102640 |
| P2093 | author name string | G Martín | |
| M A Sanz | |||
| I Jarque | |||
| J Martínez | |||
| A Sempere | |||
| J de la Rubia | |||
| G F Sanz | |||
| F Gomis | |||
| L Senent | |||
| M A Soler | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acute myeloblastic leukemia | Q1110197 |
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 1661-1667 | |
| P577 | publication date | 1993-09-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution | |
| P478 | volume | 11 |
| Q46874640 | Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients. |
| Q44517812 | An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies |
| Q73884756 | Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis |
| Q41131752 | Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status |
| Q79333289 | Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution |
| Q35122189 | Autologous stem cell transplantation for acute myeloid leukemia |
| Q43690744 | Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients |
| Q35576187 | Epidemiology and clinical burden of acute myeloid leukemia |
| Q58865966 | Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies |
| Q58865958 | Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies |
| Q40536250 | Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells |
| Q73093108 | High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia |
| Q41581068 | Pediatric blood cell transplantation |
| Q45104478 | Peripheral blood stem cell collection after intermediate-dose cytarabine in adult patients with acute myeloblastic leukemia undergoing autologous blood stem cell transplantation in first complete remission |
| Q73784841 | Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells |
| Q34383226 | Recent advances in the treatment of AML. |
| Q43539736 | Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation |
| Q41055102 | Treatment and prognostic factors in acute myeloid leukaemia |
Search more.